Biotricity (NASDAQ:BTCY) Trading Down 1.7% – Should You Sell?

Biotricity, Inc. (NASDAQ:BTCY) dropped 1.7% on Tuesday . The company traded as low as $0.2259 and last traded at $0.2260. Approximately 19,763 shares were traded during mid-day trading, a decline of 60% from the average daily volume of 49,861 shares. The stock had previously closed at $0.23.

Biotricity Stock Performance

The business has a 50 day moving average price of $0.25 and a two-hundred day moving average price of $0.36. The stock has a market cap of $6.46 million, a PE ratio of -0.21 and a beta of 1.38.

Biotricity (NASDAQ:BTCY) last announced its earnings results on Wednesday, February 11th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.04. The business had revenue of $3.99 million during the quarter. As a group, research analysts anticipate that Biotricity, Inc. will post -0.67 earnings per share for the current year.

About Biotricity

Biotricity, Inc (NASDAQ:BTCY) is a digital health company specializing in remote patient monitoring solutions across cardiovascular and chronic disease management. The firm develops and commercializes a patented wearable biosensor platform designed to capture continuous physiological data, including electrocardiogram (ECG) readings and heart rate variability. This integrated system combines lightweight, adhesive biosensors with cloud-based analytics and clinician-facing software to support early detection of cardiac arrhythmias and facilitate telehealth care delivery.

The company’s flagship offering, the Bioflux™ platform, comprises a small, single-use wearable device that transmits real-time data to a secure portal, where advanced algorithms analyze cardiac patterns and generate clinician alerts.